Kraus C, Reina-Sanchez J, Suleková Z, Ballhausen W G
Institute of Human Genetics, University of Erlangen, Germany.
Int J Cancer. 1996 Jan 26;65(3):383-8. doi: 10.1002/(SICI)1097-0215(19960126)65:3<383::AID-IJC18>3.0.CO;2-B.
Mapping analyses of monoclonal antibodies (MAbs) directed against the amino-terminus of the adenomatous polyposis coli (APC) gene product revealed that epitopes recognized by the MAbs FE9, CF11 and AC4 constitute different peptide sequences encoded by the APC exons 1, 2 and 3, respectively. The protein pattern detected with these specificity-defined immunoreagents, however, differed depending on the particular antibody used on Western blots of cellular urea extracts. APC exon 15-positive "classic" p300apc polypeptide chains were identified by the MAb FE9, MAb CF11 and the C-terminus-specific MAb IE1, but only weak signals were obtained with the AC4 MAb, which defines an exon 3-encoded epitope. In contrast with this immunoreactivity, 2 novel high m.w. products of approx. 150/160 and 200 kDa were exclusively recognized by the AC4 MAb, which was shown to bind to the APC exon 3-encoded peptide sequence SRESTGYL. A molecular form of some 400 kDa was identified to represent a disulfide-bound oligomer of the p150/160apc molecules. The novel APC-related molecules did not contain exon 1- and exon 15-encoded epitopes, as confirmed with the help of the FE9 and IE1 MAbs, respectively. This observation was corroborated by the fact that these novel proteins were not truncated in a collection of familial adenomatous polyposis patients with stop mutations in exon 15. We conclude, that APC MAb AC4-reactive p150/160 and p200 polypeptide chains represent novel genuine products of the APC gene devoid of exon 1- and exon 15-encoded protein interaction domains.
针对腺瘤性结肠息肉病(APC)基因产物氨基末端的单克隆抗体(MAb)的定位分析显示,MAb FE9、CF11和AC4识别的表位分别由APC外显子1、2和3编码的不同肽序列组成。然而,在用这些特异性定义的免疫试剂检测细胞尿素提取物的蛋白质印迹时,所检测到的蛋白质模式因所用的特定抗体而异。APC外显子15阳性的“经典”p300apc多肽链可被MAb FE9、MAb CF11和C末端特异性MAb IE1识别,但用定义外显子3编码表位的AC4 MAb仅获得微弱信号。与这种免疫反应性相反,约150/160 kDa和200 kDa的两种新型高分子量产物仅被AC4 MAb识别,AC4 MAb已证明与APC外显子3编码的肽序列SRESTGYL结合。约400 kDa的一种分子形式被鉴定为p150/160apc分子的二硫键结合寡聚体。新型APC相关分子不包含外显子1和外显子15编码的表位,分别通过FE9和IE1 MAb得到证实。这一观察结果得到以下事实的佐证:在一组外显子15存在终止突变的家族性腺瘤性息肉病患者中,这些新型蛋白质没有被截断。我们得出结论,APC MAb AC4反应性的p150/160和p200多肽链代表APC基因的新型真实产物,缺乏外显子1和外显子15编码的蛋白质相互作用结构域。